Scahill L. et al. (2001)
Journal of Child and Adolescent Psychopharmacology
Winter, 11(4), pp, 377-88.
Scahill L. et al. (2017)
Journal of Child and Adolescent Psychopharmacology
March, 27(2), pp. 125-131.
Scahill L. et al. (2016)
Journal of the American Academy of Child and Adolescent Psychiatry
May, 55(5), pp. 415-423.
Stigler K. A. et al. (2004)
A naturalistic retrospective analysis of psychostimulants in pervasive developmental disorders.
Journal of Child and Adolescent Psychopharmacology
14(1), pp. 49-56
Stigler K. A. et al. (2009)
Autism and immune factors: A comprehensive review.
Research in Autism Spectrum Disorders
pp. 840-860
Stigler K. A. , Posey D. J. , McDougle C. J. (2004)
Case report: aripiprazole for maladaptive behavior in pervasive developmental disorder.
Journal of Child and Adolescent Psychopharmacology
14(3), pp. 455-463
Stigler K. A. et al. (2010)
Paliperidone for irritability in autistic disorder.
Journal of Child and Adolescent Psychopharmacology
pp. 75-78
Stigler K. A. , McDougle C. J. (2008)
Pharmacotherapy of irritability in pervasive developmental disorders.
Child and Adolescent Psychiatric Clinics of North America
17(4), pp. 739-752
Stigler K. A. , Posey D. J. , McDougle C. J. (2006)
Ramelteon for insomnia in two youths with autistic disorder.
Journal of Child and Adolescent Psychopharmacology
16(5), pp. 631-636
Stigler K. A. , Posey D. J. , McDougle C. J. (2002)
Recent advances in the pharmacotherapy of autism.
Expert Review of Neurotherapeutics
2(4), pp. 499-510
Vitiello B. et al. (2005)
Assessment of the integrity of study blindness in a pediatric clinical trial of risperidone.
Journal of Clinical Psychopharmacology
25(6), pp. 565-569
Perceptual and Motor Skills
December, 26(10), pp. 900-908
Williams S. K. et al. (2006)
Risperidone and adaptive behavior in children with autism.
Journal of the American Academy of Child and Adolescent Psychiatry
45(4), pp. 431-439
Wink L. K. et al. (2017)
d-Cycloserine enhances durability of social skills training in autism spectrum disorder.
Molecular Autism
Wink L. K. et al. (2010)
Emerging drugs for the treatment of symptoms associated with autism spectrum disorders.
Expert Opinion on Emerging Drugs
September, 15(3), pp. 481-494
Wink L. K. , Erickson C. A. , McDougle C. J. (2010)
Current Treatment Options in Neurology
12(6), pp. 529-538.